Ampio Pharmaceuticals Inc. (AMEX:AMPE) price is hovering higher on Wednesday, September 15, jumping 25.69% above its previous close.
A look at today’s price movement shows that the recent level at last check reads $1.44, with intraday deals fluctuating between $1.44 and $1.57. The company’s 5Y monthly beta was ticking 1.76. Taking into account the 52-week price action we note that the stock hit a 52-week high of $2.98 and 52-week low of $0.72. The stock subtracted -1.37% on its value in the past month.
Ampio Pharmaceuticals Inc., which has a market valuation of $327.17 million, is expected to release its quarterly earnings report Nov 01, 2021 – Nov 05, 2021. Analysts tracking AMPE have forecast the quarterly EPS to shrink by -0.02 per share this quarter, while the same analysts predict the annual EPS to hit -$0.08 for the year 2021 and up to -$0.07 for 2022. In this case, analysts estimate an annual EPS growth of 11.10% for the year and 12.50% for the next year.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. On the technical perspective front, indicators give AMPE a short term outlook of Hold on average. Looking at the stock’s medium term indicators we note that it is averaging as a 50% Sell, while an average of long term indicators are currently assigning the stock as 50% Buy.
Here is a look at the average analyst rating for the stock as represented on a scale of 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock is strong buy or strong sell respectively. Specifically, 1 analysts have assigned AMPE a recommendation rating as follows: 0 rate it as a Hold; 1 advise Buy while 0 analyst(s) assign an Overweight rating. 0 analyst(s) have tagged the Ampio Pharmaceuticals Inc. (AMPE) stock as Underweight, with 0 recommending Sell. In general, analysts have rated the stock Buy, a scenario likely to bolster investors out for an opportunity to add to their holdings of the company’s shares.
The overview shows that AMPE’s price is at present 18.84% off the SMA20 and 20.78% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 61.64, with weekly volatility standing at 7.96%. The indicator jumps to 7.24% when calculated based on the past 30 days. Ampio Pharmaceuticals Inc. (AMEX:AMPE)’s beta value is holding at 1.75, while the average true range (ATR) indicator is currently reading 0.11. Considering analysts have assigned the stock a price target range of $4.00-$4.00 as the low and high respectively, we find the trailing 12-month average consensus price target to be $4.00. Based on this estimate, we see that today’s price at last check is roughly -120.99% off the estimated low and -120.99% off the forecast high. Investors will no doubt be excited to see the share price fall to $4.00, which is the median consensus price, and at that level AMPE would be -120.99% from recent price.
Turning out attention to how the Ampio Pharmaceuticals Inc. stock has performed in comparison to its peers in the industry, here’s what we find: AMPE’s stock is 25.69% on the day and 73.75% in the past 12 months, while Aerie Pharmaceuticals Inc. (AERI) traded 0.19% in the latest session and is positioned 42.00% up on its price 12 months ago. Another comparison is with Johnson & Johnson (JNJ) whose stock price is up 0.32% in the current trading session, and has flourished 11.09% over the past year. Also, Flexion Therapeutics Inc. (FLXN) is currently showing up trend of 5.90% while its price kept floating at -51.47% over the past year. Elsewhere in the market, the S&P 500 Index has rallied 0.24% in today’s early trading, with the Dow Jones Industrial also seeing a positive session on the day with 0.21%.
An analysis of the Ampio Pharmaceuticals Inc. (AMEX:AMPE) stock in terms of its daily trading volume indicates that the 3-month average is 1.84 million. However, this figure increases on the past 10-day timeline to an average of 0.89 million.
Current records show that the company has 196.18M in outstanding shares. The insiders’ percentage holdings are 7.05% of outstanding shares while the percentage share held by institutions stands at 27.42%. The stats also highlight that short interest as of Jul 29, 2021, stood at 25.29 million shares, which puts the short ratio at the time at 21.22. From this we can glean that short interest is 12.61% of company’s current outstanding shares. Notably, we see that shares short in July fall slightly given the previous month’s figure stood at 26.15 million. But the -9.43% downside, the stock’s price has registered year-to-date as of today’s value, will likely reignite investor interest given the prospect of it rallying even higher.